Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls

被引：0
|
作者：
Eli P. Darnell
Meghan J. Mooradian
Erez N. Baruch
Melis Yilmaz
Kerry L. Reynolds
机构：
[1] Bartlett,Division of Internal Medicine
[2] Massachusetts General Hospital,Division of Medical Oncology
[3] Bartlett,Ella Lemelbaum Institute for Immuno
[4] Massachusetts General Hospital,Oncology
[5] Harvard Medical School,Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine
[6] Sheba Medical Center,undefined
[7] Tel Aviv University,undefined
来源：
Current Oncology Reports | 2020年 / 22卷
关键词：
Melanoma; Toxicity; Immune-related adverse event; irAE; Ipilimumab; Pembrolizumab; Nivolumab; Anti-CTLA-4; Anti-PD-1; Colitis; Hepatitis; Pneumonitis; Myocarditis; Hypothyroidism; Diabetes; Hypophysitis; Steroids; Immunosuppression; Immunotherapy; ICI-induced toxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls
    Darnell, Eli P.
    Mooradian, Meghan J.
    Baruch, Erez N.
    Yilmaz, Melis
    Reynolds, Kerry L.
    [J]. CURRENT ONCOLOGY REPORTS, 2020, 22 (04)
  • [2] Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management
    Javaid, Anadil
    Bennett, Catherine
    Rao, Aparna
    Spain, Lavinia
    [J]. PHARMACEUTICAL MEDICINE, 2024, 38 (01) : 25 - 38
  • [3] Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management
    Anadil Javaid
    Catherine Bennett
    Aparna Rao
    Lavinia Spain
    [J]. Pharmaceutical Medicine, 2024, 38 : 25 - 38
  • [4] Management of immune-related adverse events (irAEs) - what needs to be respected?
    Thomssen, Christoph
    [J]. GYNAKOLOGE, 2022, 55 (05): : 344 - 350
  • [5] Editorial: Immune-related adverse Events (irAEs) of biopharmaceuticals
    Batista-Duharte, Alexander
    Alino, Salvador F. F.
    [J]. FRONTIERS IN ALLERGY, 2023, 4
  • [6] Diagnosis and Management of Immune Related Adverse Events (irAEs) in Cancer Immunotherapy
    Liu, Yi-He
    Zang, Xin-Yuan
    Wang, Jin-Cheng
    Huang, Shan-Shan
    Xu, Jiang
    Zhang, Peng
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2019, 120
  • [7] The chronology of immune-related adverse events (irAEs)-mechanistic implications
    Mazahreh, Farah
    Safar, Haya
    Mazahreh, Liyan
    Safar, A. Mazin
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [8] Management of immune-related adverse events (irAEs) in clinical practice, support team of Chiba University Hospital
    Iwasawa, Shunichiro
    Ebata, Takahiro
    Ishiwata, Tsukasa
    Ikari, Jun
    Sakaida, Emiko
    Iwasawa, Mari
    Arai, Makoto
    Kanda, Tatsuro
    Misawa, Sonoko
    Takiguchi, Yuichi
    [J]. ANNALS OF ONCOLOGY, 2017, 28 : 95 - 95
  • [9] DISTRIBUTION OF IMMUNE-RELATED ADVERSE EVENTS (IRAES) IN SOLID MALIGNANCIES
    Kaakour, Dalia
    Slaught, Matthew
    Azizi, Armon
    Kroening, Gianna
    Valerin, Jennifer
    Mar, Nataliya
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1293 - A1293
  • [10] Diagnosis and Management of Rare Immune-Related Adverse Events
    Schoenfeld, Sara R.
    Aronow, Mary E.
    Leaf, Rebecca Karp
    Dougan, Michael
    Reynolds, Kerry L.
    [J]. ONCOLOGIST, 2020, 25 (01): : 6 - 14
12345